Skip to main content
. Author manuscript; available in PMC: 2011 Jun 23.
Published in final edited form as: Pediatr Cardiol. 2010 Oct 21;32(1):1–7. doi: 10.1007/s00246-010-9795-5

Table 2.

Rejection characteristics

Variable High-dose group Low-dose group p-Value
Prerejection FS 33.78 ± 2.391 33.52 ± 1.716 0.93
FS at time of diagnosis 22.688 ± 13.638 23.944 ± 9.6469 0.94
LVEDD 44.168 ± 6.5936 43.31 ± 9.2057 0.69
TR at time of diagnosis 12 (3 moderate and 1 severe) 37 (12 moderate and 1 severe) 0.63
MR at time of diagnosis 9 (1 moderate and 1 severe) 29 (4 moderate and no severe) 0.23
Mitral inflow abnormalities at time of diagnosis 9 19 0.37
RAP pressure (mmHg) 14.333 ± 6.4395 17.15 ± 6.9757 0.38
PCWP (mmHg) 20.833 ± 4.9967 20.238 ± 6.6099 0.81
Pericardial or pleural effusions at the time of diagnosis 12 7 0.23
Presence of TCD prior to rejection episode 2 9 0.16

FS = fractional shortening; LVEDD = left ventricular end diastolic dimension; TR = tricuspid valve regurgitation; MR = mitral valve regurgitation; RAP = right atrial pressure; PCWP = pulmonary capillary wedge pressure; TCD = transplant coronary disease